Chimin(SH:603222) Xin Lang Cai Jing·2026-01-16 01:46Group 1 - The core viewpoint of the news is that Jimin Health has experienced a decline in stock price and significant changes in financing activities, indicating potential liquidity issues and investor sentiment challenges [1][2] Group 2 - On January 15, Jimin Health's stock fell by 1.95%, with a trading volume of 145 million yuan. The financing buy-in amount was 6.0087 million yuan, while the financing repayment was 11.2016 million yuan, resulting in a net financing outflow of 5.1929 million yuan [1] - As of January 15, the total balance of margin trading for Jimin Health was 222 million yuan, which represents 4.42% of its market capitalization. This financing balance is above the 60th percentile of the past year, indicating a high level [1] - In terms of securities lending, Jimin Health repaid 100 shares on January 15, with no shares sold, resulting in a securities lending balance of 5.26 million yuan, which is above the 50th percentile of the past year [1] Group 3 - As of September 30, the number of shareholders for Jimin Health increased to 58,100, a rise of 107%. However, the average number of circulating shares per person decreased by 51.69% to 9,035 shares [2] - For the period from January to September 2025, Jimin Health reported a revenue of 545 million yuan, a year-on-year decrease of 20.21%. The net profit attributable to shareholders was -77.1504 million yuan, a significant decline of 371.51% [2] Group 4 - Since its A-share listing, Jimin Health has distributed a total of 127 million yuan in dividends, with 10.7447 million yuan distributed over the past three years [3]